Loading clinical trials...
Loading clinical trials...
This single-arm, single-center phase II trial evaluates the safety and efficacy of a non-continuous radio-immunotherapy strategy for recurrent nasopharyngeal carcinoma (NPC) unsuitable for surgery. In...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Jiangxi Provincial Cancer Hospital
NCT07459296 · Nasopharyngeal Carcinoma (NPC)
NCT07340515 · Nasopharyngeal Carcinoma (NPC)
NCT07188584 · Nasopharyngeal Carcinoma (NPC)
NCT06982300 · Nasopharyngeal Carcinoma (NPC)
NCT07085988 · Nasopharyngeal Carcinoma (NPC)
Jiangxi Cancer Hospital
Nanchang, Jiangxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions